ResMed Inc. closed 10.21% short of its 52-week ... Editor's Note: This story was auto-generated by Automated Insights, an automation technology provider, using data from Dow Jones and FactSet.

ResMed specializes in designing and manufacturing devices and software solutions for sleep apnea, chronic obstructive pulmonary disease (COPD), and other respiratory conditions. Its commitment to ...

With a market cap of $32.6 billion, San Diego, California-based ResMed Inc. (RMD) is a global leader in designing, manufacturing, and distributing medical devices and cloud-based software ...

ResMed Inc.’s RMD adjusted earnings per share (EPS) in the second quarter of fiscal 2025 were $2.43, up 29.2% year over year. The metric beat the Zacks Consensus Estimate by 5.6%. The adjustments ...